Thomas Shrader Score: 18
Analyst at
BTIG
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-11.7%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
27%
4 W / 11 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
33%
3 W / 6 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
11%
1 W / 8 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 9 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
27%
4 W / 11 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
27%
4 W / 11 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 05, 2026 |
Gain Therapeutics Inc
GANX
|
BUY |
$5.00
Est. +189%
|
$1.73 | $1.76 |
Pending
|
$1.26
-27.2%
|
| Sep 24, 2026 |
Arcturus Therapeutics Holdings Inc
ARCT
|
BUY |
$20.00
Est. +50%
|
$13.30 | $15.17 |
Pending
|
$10.34
-22.3%
|
| Aug 13, 2026 |
Alto Neuroscience Inc.
ANRO
|
BUY |
$37.00
Est. +27%
|
$29.18 | $37.43 |
Precision Hit (±3%)
|
$21.94
-24.8%
|
| Apr 24, 2026 |
NeOnc Technologies Holdings Inc.
NTHI
|
BUY |
$15.00
Est. +213%
|
$4.79 | $6.84 |
Pending
|
$2.70
-43.6%
|
| Mar 18, 2026 |
Harrow Inc
HROW
|
BUY |
$63.00
Est. +82%
|
$34.68 | $47.50 |
Pending
|
$27.28
-21.3%
|
| Feb 17, 2026 |
Alto Neuroscience Inc.
ANRO
|
BUY |
$28.00
Est. +66%
|
$16.89 | $37.43 |
Target Met
|
$21.94
+29.9%
|
| Jan 20, 2026 |
Opus Genetics, Inc.
IRD
|
BUY |
$7.00
Est. +233%
|
$2.10 | $4.88 |
Pending
|
$4.64
+121.0%
|
| Aug 18, 2025 |
Stoke Therapeutics Inc
STOK
|
BUY |
$28.00
Est. +55%
|
$18.10 | $40.22 |
Target Met
|
$24.17
+33.5%
|
| Mar 10, 2025 |
Arcturus Therapeutics Holdings Inc
ARCT
|
BUY |
$48.00
Est. +230%
|
$14.55 | $24.08 |
Miss
|
$10.34
-28.9%
|
| Jan 07, 2025 |
Denali Therapeutics Inc
DNLI
|
BUY |
$32.00
Est. +51%
|
$21.18 | $24.35 |
Miss
|
$17.61
-16.9%
|
| Oct 14, 2024 |
Denali Therapeutics Inc
DNLI
|
BUY |
$35.00
Est. +25%
|
$28.00 | $33.32 |
Miss
|
$17.61
-37.1%
|
| Sep 23, 2024 |
Biohaven Ltd
BHVN
|
BUY |
$59.00
Est. +27%
|
$46.56 | $55.58 |
Miss
|
$10.78
-76.8%
|
| May 30, 2024 |
AC Immune SA
ACIU
|
BUY |
$8.00
Est. +102%
|
$3.97 | $4.26 |
Miss
|
$2.39
-39.8%
|
| May 20, 2024 |
Ovid Therapeutics Inc
OVID
|
BUY |
$11.00
Est. +250%
|
$3.14 | $1.47 |
Miss
|
$2.15
-31.5%
|
| Nov 13, 2022 |
Gain Therapeutics Inc
GANX
|
BUY |
$10.00
Est. +212%
|
$3.21 | - | - |
$1.26
-60.7%
|
Gain Therapeutics Inc
GANX
Oct 05, 2026
Signal & Target
BUY
$5.00
Start Price
$1.73
Best Price (1Y)
$1.76
Current Price
$1.26
Return
-27.2%
Arcturus Therapeutics Holdings Inc
ARCT
Sep 24, 2026
Signal & Target
BUY
$20.00
Start Price
$13.30
Best Price (1Y)
$15.17
Current Price
$10.34
Return
-22.3%
Alto Neuroscience Inc.
ANRO
Aug 13, 2026
Signal & Target
BUY
$37.00
Start Price
$29.18
Best Price (1Y)
$37.43
Current Price
$21.94
Return
-24.8%
NeOnc Technologies Holdings Inc.
NTHI
Apr 24, 2026
Signal & Target
BUY
$15.00
Start Price
$4.79
Best Price (1Y)
$6.84
Current Price
$2.70
Return
-43.6%
Harrow Inc
HROW
Mar 18, 2026
Signal & Target
BUY
$63.00
Start Price
$34.68
Best Price (1Y)
$47.50
Current Price
$27.28
Return
-21.3%
Alto Neuroscience Inc.
ANRO
Feb 17, 2026
Signal & Target
BUY
$28.00
Start Price
$16.89
Best Price (1Y)
$37.43
Current Price
$21.94
Return
+29.9%
Opus Genetics, Inc.
IRD
Jan 20, 2026
Signal & Target
BUY
$7.00
Start Price
$2.10
Best Price (1Y)
$4.88
Current Price
$4.64
Return
+121.0%
Stoke Therapeutics Inc
STOK
Aug 18, 2025
Signal & Target
BUY
$28.00
Start Price
$18.10
Best Price (1Y)
$40.22
Current Price
$24.17
Return
+33.5%
Arcturus Therapeutics Holdings Inc
ARCT
Mar 10, 2025
Signal & Target
BUY
$48.00
Start Price
$14.55
Best Price (1Y)
$24.08
Current Price
$10.34
Return
-28.9%
Denali Therapeutics Inc
DNLI
Jan 07, 2025
Signal & Target
BUY
$32.00
Start Price
$21.18
Best Price (1Y)
$24.35
Current Price
$17.61
Return
-16.9%
Denali Therapeutics Inc
DNLI
Oct 14, 2024
Signal & Target
BUY
$35.00
Start Price
$28.00
Best Price (1Y)
$33.32
Current Price
$17.61
Return
-37.1%
Biohaven Ltd
BHVN
Sep 23, 2024
Signal & Target
BUY
$59.00
Start Price
$46.56
Best Price (1Y)
$55.58
Current Price
$10.78
Return
-76.8%
AC Immune SA
ACIU
May 30, 2024
Signal & Target
BUY
$8.00
Start Price
$3.97
Best Price (1Y)
$4.26
Current Price
$2.39
Return
-39.8%
Ovid Therapeutics Inc
OVID
May 20, 2024
Signal & Target
BUY
$11.00
Start Price
$3.14
Best Price (1Y)
$1.47
Current Price
$2.15
Return
-31.5%
Gain Therapeutics Inc
GANX
Nov 13, 2022
Signal & Target
BUY
$10.00
Start Price
$3.21
Best Price (1Y)
-
Current Price
$1.26
Return
-60.7%